SCYNEXIS, Inc.

SCYNEXIS, Inc.verified

SCYX

Price:

$4.23

Market Cap:

$26.60M

SCYNEXIS, Inc. is a biotechnology firm based in the U.S. dedicated to developing therapies for fungal infections. The company's flagship product, BREXAFEMME (ibrexafungerp tablets), has received approval for the treatment of vulvovaginal candidiasis (VVC). Furthermore, SCYNEXIS is progressing ibrexafungerp, its leading drug candidate, as both an oral and intravenous medicine designed to address various fungal conditions, including recurrent VVC, invasive aspergillosis, invasive candidiasis, and challenging refractory invasive fungal infections. Ibrexafungerp has successfully completed the Phase 3 CANDLE study, which evaluated its effectiveness in preventing recurrent VVC. SCYNEXIS has also e...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2014-05-02

Stock Exchange

NASDAQ

Ticker

SCYX

The ROE as of June 2026 (TTM) for SCYNEXIS, Inc. (SCYX) is -57.16%

According to SCYNEXIS, Inc.’s latest financial reports and current stock price. The company's current ROE is -57.16%. This represents a change of 247.44% compared to the average of -16.45% of the last 4 quarters.

SCYNEXIS, Inc. (SCYX) Historical ROE (quarterly & annually)

How has SCYX ROE performed in the past?

The mean historical ROE of SCYNEXIS, Inc. over the last ten years is -288.87%. The current -57.16% ROE has changed -80.21% with respect to the historical average. Over the past ten years (40 quarters), SCYX's ROE was at its highest in in the June 2023 quarter at 131.35%. The ROE was at its lowest in in the December 2022 quarter at -446.30%.

Quarterly (TTM)
Annual

Average

-288.87%

Median

-82.89%

Minimum

-1942.75%

Maximum

91.88%

SCYNEXIS, Inc. (SCYX) ROE by Quarter and Year

Discovering the peaks and valleys of SCYNEXIS, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.34%

Maximum Annual ROE = 91.88%

Minimum Annual Increase = -142.06%

Minimum Annual ROE = -1942.75%

Quarterly (TTM)
Annual
YearROEChange
2025-17.44%-54.89%
2024-38.65%-142.06%
202391.88%-104.73%
2022-1942.75%2.34%
2021-79.66%-67.15%
2020-242.49%-41.78%
2019-416.52%943.13%
2018-39.93%-65.89%
2017-117.05%35.90%
2016-86.13%10.75%

SCYNEXIS, Inc. (SCYX) Average ROE

How has SCYX ROE performed in the past?

The current ROE of SCYNEXIS, Inc. (SCYX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

11.93%

5-year avg

-397.32%

10-year avg

-288.87%

SCYNEXIS, Inc. (SCYX) ROE vs. Peers

How is SCYX’s ROE compared to its peers?

SCYNEXIS, Inc.’s ROE is greater than Talphera, Inc. (-92.98%), greater than Cosmos Health Inc. (-96.48%), greater than Cadrenal Therapeutics, Inc. Common Stock (-411.02%), greater than Exicure, Inc. (-179.41%), greater than Klotho Neurosciences, Inc. (-137.57%), greater than CollPlant Biotechnologies Ltd. (-160.28%), greater than Sonnet BioTherapeutics Holdings, Inc. (-518.10%), greater than Nexalin Technology, Inc. (-191.88%), greater than NeurAxis, Inc. (-185.74%), less than NeuroSense Therapeutics Ltd. (173.60%),

Build a custom stock screener for SCYNEXIS, Inc. (SCYX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SCYNEXIS, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SCYNEXIS, Inc. (SCYX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SCYNEXIS, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is SCYNEXIS, Inc.'s ROE?

How is the ROE calculated for SCYNEXIS, Inc. (SCYX)?

What is the highest ROE for SCYNEXIS, Inc. (SCYX)?

What is the 3-year average ROE for SCYNEXIS, Inc. (SCYX)?

What is the 5-year average ROE for SCYNEXIS, Inc. (SCYX)?

How does the current ROE for SCYNEXIS, Inc. (SCYX) compare to its historical average?